Jennifer H Gunter

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersBiomaterialsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review.

|Oct 24, 2024
Humanized In Vivo Bone Tissue Engineering: In Vitro Preculture Conditions Control the Structural, Cellular, and Matrix Composition of Humanized Bone Organs.

Agathe Bessot, Flavia Medeiros Savi, Jennifer Gunter

|Jul 18, 2024
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer.

Charles L Bidgood, Lisa K Philp, Anja Rockstroh

|Jan 28, 2023
GelMA and Biomimetic Culture Allow the Engineering of Mineralized, Adipose, and Tumor Tissue Human Microenvironments for the Study of Advanced Prostate Cancer In Vitro and In Vivo.

Agathe Bessot, Jennifer Gunter, David Waugh

|Dec 26, 2022
Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models.

Nan Fang Wang, Toni Rose Jue, Jeff Holst

|Jun 27, 2022
TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity.

Fernando Souza-Fonseca-Guimaraes, Gustavo R Rossi, Laura F Dagley

Pageof 2

Frequent Collaborators

2 joint publications

Agathe Bessot

2 joint publications

David Waugh

2 joint publications

Dietmar W Hutmacher

2 joint publications

Jacqui McGovern